SI
LLY icon

Stephens Inc’s Eli Lilly LLY Stock Holding History

Stephens Inc’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$34.1M Sell
36,913
-486
-1% -$493K 0.43% 54
2025
Q4 		$40.3M Sell
37,399
-912
-2% -$872K 0.5% 39
2025
Q3 		$29.2M Buy
38,311
+530
+1% +$394K 0.37% 57
2025
Q2 		$29.5M Buy
37,781
+1,296
+4% +$1.01M 0.4% 52
2025
Q1 		$30.1M Buy
36,485
+1,197
+3% +$996K 0.44% 52
2024
Q4 		$27.2M Sell
35,288
-14,715
-29% -$12.2M 0.38% 63
2024
Q3 		$44.3M Sell
50,003
-2,447
-5% -$2.2M 0.63% 30
2024
Q2 		$47.5M Buy
52,450
+18,037
+52% +$14.4M 0.72% 24
2024
Q1 		$26.8M Buy
34,413
+3,885
+13% +$2.76M 0.42% 53
2023
Q4 		$17.8M Buy
30,528
+512
+2% +$299K 0.31% 83
2023
Q3 		$16.1M Buy
30,016
+384
+1% +$198K 0.31% 78
2023
Q2 		$13.9M Sell
29,632
-101
-0.3% -$42.4K 0.25% 99
2023
Q1 		$10.2M Sell
29,733
-2,525
-8% -$852K 0.2% 119
2022
Q4 		$11.8M Sell
32,258
-775
-2% -$275K 0.24% 97
2022
Q3 		$10.7M Sell
33,033
-403
-1% -$128K 0.23% 100
2022
Q2 		$10.8M Buy
33,436
+10,581
+46% +$3.18M 0.22% 104
2022
Q1 		$6.54M Sell
22,855
-5,068
-18% -$1.3M 0.11% 203
2021
Q4 		$7.71M Sell
27,923
-167
-0.6% -$42.3K 0.12% 194
2021
Q3 		$6.49M Sell
28,090
-68
-0.2% -$16.8K 0.1% 215
2021
Q2 		$6.46M Buy
28,158
+4,053
+17% +$814K 0.1% 225
2021
Q1 		$4.5M Sell
24,105
-1,438
-6% -$281K 0.07% 265
2020
Q4 		$4.31M Sell
25,543
-1,558
-6% -$233K 0.08% 263
2020
Q3 		$4.01M Sell
27,101
-3,672
-12% -$568K 0.08% 247
2020
Q2 		$5.05M Sell
30,773
-3,155
-9% -$484K 0.11% 201
2020
Q1 		$4.71M Sell
33,928
-1,541
-4% -$212K 0.13% 174
2019
Q4 		$4.66M Sell
35,469
-6,950
-16% -$806K 0.1% 230
2019
Q3 		$4.74M Buy
42,419
+5,970
+16% +$665K 0.1% 224
2019
Q2 		$4.04M Sell
36,449
-4,686
-11% -$552K 0.09% 252
2019
Q1 		$5.34M Sell
41,135
-2,612
-6% -$318K 0.13% 187
2018
Q4 		$5.06M Sell
43,747
-1,419
-3% -$159K 0.14% 165
2018
Q3 		$4.85M Buy
45,166
+566
+1% +$56.6K 0.12% 209
2018
Q2 		$3.81M Buy
44,600
+253
+0.6% +$20.8K 0.12% 212
2018
Q1 		$3.43M Buy
44,347
+5,375
+14% +$433K 0.13% 183
2017
Q4 		$3.29M Sell
38,972
-4,020
-9% -$342K 0.12% 192
2017
Q3 		$3.68M Sell
42,992
-2,692
-6% -$221K 0.13% 161
2017
Q2 		$3.76M Buy
45,684
+1,661
+4% +$136K 0.13% 178
2017
Q1 		$3.7M Buy
44,023
+1,901
+5% +$152K 0.13% 173
2016
Q4 		$3.1M Buy
42,122
+1,514
+4% +$113K 0.13% 189
2016
Q3 		$3.26M Buy
40,608
+1,106
+3% +$88.5K 0.14% 153
2016
Q2 		$3.11M Buy
39,502
+1,786
+5% +$134K 0.14% 159
2016
Q1 		$2.72M Buy
37,716
+2,269
+6% +$172K 0.13% 166
2015
Q4 		$2.99M Buy
35,447
+3,426
+11% +$284K 0.15% 146
2015
Q3 		$2.68M Sell
32,021
-4,085
-11% -$345K 0.14% 158
2015
Q2 		$3.02M Sell
36,106
-7,321
-17% -$558K 0.14% 172
2015
Q1 		$3.15M Buy
43,427
+1,667
+4% +$119K 0.14% 164
2014
Q4 		$2.88M Sell
41,760
-25,958
-38% -$1.75M 0.14% 167
2014
Q3 		$4.39M Buy
67,718
+11,442
+20% +$724K 0.22% 105
2014
Q2 		$3.5M Sell
56,276
-4,608
-8% -$275K 0.18% 144
2014
Q1 		$3.58M Buy
60,884
+3,144
+5% +$175K 0.2% 130
2013
Q4 		$2.94M Sell
57,740
-2,030
-3% -$102K 0.15% 151
2013
Q3 		$3.01M Sell
59,770
-8,846
-13% -$463K 0.16% 132
2013
Q2 		$3.37M Buy
+68,616
New +$3.73M 0.19% 103

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Stephens Inc's LLY Position: Q1 2026 in Review

Stephens Inc reduced its Eli Lilly (LLY) stake by 1.3% in Q1 2026, selling an estimated $493K and leaving 36,913 shares worth $34.1M. The position accounts for 0.43% of the portfolio, ranked #54.

Stephens Inc first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $47.5M in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Stephens Inc held 36,913 shares of Eli Lilly worth $34.1M as of Q1 2026.
  • Stephens Inc sold 486 Eli Lilly shares in Q1 2026, an estimated $493K.
  • Eli Lilly made up 0.43% of Stephens Inc's portfolio in Q1 2026, its #54 holding.
  • Stephens Inc first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Stephens Inc's Eli Lilly position peaked at $47.5M in Q2 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Stephens Inc's 13F filing for Q1 2026, filed 28 Apr 2026.